LEP and cancer: When focused on obesity-related cancer mortality only (Table 5), higher leptin levels were associated with reduced risk of obesity-related cancer mortality (adjusted HR per SD log leptin: 0.59, 95% CI: 0.47-0.75), an association that was modestly attenuated after adjustment for baseline health behaviors and comorbidities.